UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 207

Sortiert nach

Editorial: Molecular Mechanisms in Cancer Endocrinology With Clinical Implications

Frontiers in endocrinology (Lausanne), 2022-02, Vol.13, p.837705-837705

Nilubol, Naris

2022

Volltextzugriff (PDF)

New Therapies for Advanced Thyroid Cancer

Frontiers in endocrinology (Lausanne), 2020-05, Vol.11, p.82-82

2020

Volltextzugriff (PDF)

The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment

Frontiers in immunology, 2021-04, Vol.12, p.656908

2021

Volltextzugriff (PDF)

Current Status and Future Targeted Therapy in Adrenocortical Cancer

Frontiers in endocrinology (Lausanne), 2021-03, Vol.12, p.613248-613248

2021

Volltextzugriff (PDF)

Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer

Cancers, 2022-10, Vol.14 (21), p.5245

2022

Volltextzugriff (PDF)

Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases

Clinical cancer research, 2017-09, Vol.23 (17), p.5044-5054

2017

Volltextzugriff (PDF)

Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma

Clinical cancer research, 2016-07, Vol.22 (14), p.3458-3466

2016

Volltextzugriff (PDF)

Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure

Oncotarget, 2018-11, Vol.9 (87), p.35723-35725

2018

Volltextzugriff (PDF)

Disease-Specific Survival by Treatment Modality in Patients with Stage IE Primary Thyroid Lymphoma: Discussion of Risks and Benefits

Annals of surgical oncology, 2024-03, Vol.31 (3), p.1436-1437

Nilubol, Naris

2024

Volltextzugriff (PDF)

Advances in Biomarker-Driven Targeted Therapies in Thyroid Cancer

Cancers, 2021-12, Vol.13 (24), p.6194

2021

Volltextzugriff (PDF)

ASO Author Reflections: Predicting Postoperative Resolution of Hypertension in Primary Hyperaldosteronism

Annals of surgical oncology, 2021-11, Vol.28 (12), p.7496-7496

2021

Volltextzugriff (PDF)

MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors

Surgery, 2013-12, Vol.154 (6), p.1224-1229

2013

Volltextzugriff (PDF)

Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers

Clinical cancer research, 2016-09, Vol.22 (17), p.4491-4504

2016

Volltextzugriff (PDF)

Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms

Clinical cancer research, 2017-09, Vol.23 (17), p.5302-5310

2017

Volltextzugriff (PDF)

"Cutting the Support" to Improve Treatment Efficacy in Thyroid Cancer by Targeting Tumor Microenvironment

The journal of clinical endocrinology and metabolism, 2022-03, Vol.107 (4), p.e1758-e1759

Nilubol, Naris

2022

Volltextzugriff (PDF)

Hyperparathyroidism-jaw tumor syndrome: Results of operative management

Surgery, 2014-12, Vol.156 (6), p.1315-1325

2014

Volltextzugriff (PDF)

Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis

Surgery, 2016-05, Vol.159 (5), p.1382-1389

2016

Volltextzugriff (PDF)

Contralateral Suppression Index Does Not Predict Clinical Cure in Patients Undergoing Surgery for Primary Aldosteronism

Annals of surgical oncology, 2021-11, Vol.28 (12), p.7487-7495

2021

Volltextzugriff (PDF)

Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors

Surgery, 2016, Vol.159 (1), p.311-319

2016

Volltextzugriff (PDF)

Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery

Annals of surgery, 2019-04, Vol.269 (4), p.741

2019

Volltextzugriff (PDF)

SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma

Surgery, 2017-01, Vol.161 (1), p.230-239

2017

Volltextzugriff (PDF)

Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome

The journal of clinical endocrinology and metabolism, 2015-12, Vol.100 (12), p.4498-4504

2015

Volltextzugriff (PDF)

miR30a inhibits LOX expression and anaplastic thyroid cancer progression

Cancer research (Chicago, Ill.), 2015-01, Vol.75 (2), p.367-377

2015

Volltextzugriff (PDF)

The Presence of SDHB Mutations Should Modify Surgical Indications for Carotid Body Paragangliomas

Annals of surgery, 2014-07, Vol.260 (1), p.158-162

2014

Volltextzugriff (PDF)

Surgical Resection of Pheochromocytomas and Paragangliomas is Associated with Lower Cholesterol Levels

World journal of surgery, 2020-02, Vol.44 (2), p.552-560

2020

Volltextzugriff (PDF)

1 – 25 von 207

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of The American College Of Surgeons

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(198)
Mit Volltextzugriff
(187)

Publikationsform

Sprache

Englisch
(207)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Editorial: Molecular Mechanisms in Cancer Endocrinology With Clinical Implications

New Therapies for Advanced Thyroid Cancer

The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment

Current Status and Future Targeted Therapy in Adrenocortical Cancer

Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer

Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases

Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma

Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure

Disease-Specific Survival by Treatment Modality in Patients with Stage IE Primary Thyroid Lymphoma: Discussion of Risks and Benefits

Advances in Biomarker-Driven Targeted Therapies in Thyroid Cancer

ASO Author Reflections: Predicting Postoperative Resolution of Hypertension in Primary Hyperaldosteronism

MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors

Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers

Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms

"Cutting the Support" to Improve Treatment Efficacy in Thyroid Cancer by Targeting Tumor Microenvironment

Hyperparathyroidism-jaw tumor syndrome: Results of operative management

Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis

Contralateral Suppression Index Does Not Predict Clinical Cure in Patients Undergoing Surgery for Primary Aldosteronism

Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors

Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery

SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma

Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome

miR30a inhibits LOX expression and anaplastic thyroid cancer progression

The Presence of SDHB Mutations Should Modify Surgical Indications for Carotid Body Paragangliomas

Surgical Resection of Pheochromocytomas and Paragangliomas is Associated with Lower Cholesterol Levels

Aktive Filter

Suchergebnisse filtern